Stock Track | CSL Soars 5.02% Intraday on UK Regulatory Approval for AUJEMFLU Vaccine

Stock Track
06/05

CSL LIMITED's stock soared 5.02% during intraday trading on Friday, following positive regulatory news from the United Kingdom.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for CSL's adjuvanted trivalent influenza vaccine, AUJEMFLU. The approval allows the vaccine to be marketed to protect adults aged 50 and over against flu, potentially opening a significant new market for the company's product portfolio.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10